Navigation Links
Herborium Group, Inc. Announces No Disruptions From Hurricane Sandy
Date:11/5/2012

FORT LEE, N.J., Nov. 5, 2012 /PRNewswire/ -- Herborium Group, Inc., (OTC Pink: HBRM) www.herborium.com, a Botanical Therapeutics® Company is happy to inform investors that the company operations have not been disrupted by hurricane Sandy. At the same time management thanks all of those who have expressed their concerns for the well being of our people and the company.

"Optimized business model and pure luck had kept Herborium out of the major impact of Sandy," stated Dr. Agnes P. Olszewski, Herborium's CEO and Chairwoman.

"We are moving forward with preparations to launch our unique all herbal energy formula Lasting Energy®.  This launch is especially important in light of recent serious problems and ongoing investigation of caffeine, sugar and Vit. B-Complex based energy products," Added Dr. Olszewski.

"We are also continuing our aggressive marketing of AcnEase®, proprietary all herbal acne treatment already present on the markets of North America, Europe, Australia and Asia.

"We will update investors on latest developments related to advancement of Lasting Energy® and AcnEase® the week of November 12th ," Concluded Dr. Olszewski. 

Once again thank you to all who have been concern about us, and our hearts go out to victims of Sandy.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage.  The company sells its products in the US and Europe. For more information on the company and its products, please visit www.herborium.com,  www.acnease.com and www.herboriumsh.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com


'/>"/>
SOURCE Herborium Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Herborium Group Achieves Major Milestones While Making Significant Progress On All Fronts Of Marketing Its Products
2. Herborium Group Reports Record 6 Month Revenues
3. Herborium Announces Continuing Progress In Key Strategic Initiatives
4. Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC
5. Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
6. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
7. Rivalz Sports Group, Inc Sportstalk Station WRSO 810 AM Orlando Officially Takes Over And Goes Live With Sports Programming
8. Huntzinger Management Group, Inc., (HMG) Reporting Significant Growth in 2012
9. The SSI Group, Inc. President and CEO Bobby Smith Announces Retirement
10. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
11. MEI Pharma Announces $27.5 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
(Date:12/6/2016)... 2016  Nearly 30 million people in ... of diabetes. 1 However, nearly 40% of diabetes ... (hyperglycemia) and significant glucose variability. 2 These patients are ... events. If left untreated, hyperglycemia can lead to cardiovascular ... blindness. 3 As part of Diabetes ...
(Date:12/6/2016)... 2016  Arcturus Therapeutics, Inc. ("Arcturus" or the ... that it entered into collaboration with Takeda Pharmaceutical ... treatment of NASH and other gastrointestinal (GI) related ... and UNA Oligomer chemistry. The financial terms were ... to and expertise in GI disorders, we are ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 07, 2016 , ... They are musicians and librarians, fashion designers and fitness ... from New England and around the nation. What do they have in common? All ... a beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan International ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... and financial consultation services to residents in the Sacramento/Folsom region, is initiating a ... treatment facility. , The Another Choice Another Chance treatment center in Sacramento works ...
(Date:12/7/2016)... ... ... A. Kevin Spann Insurance, a New York-based firm offering insurance and financial consultation ... drive to raise funds that will benefit the Marine Corps League. , The Marine ... Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans to generate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
Breaking Medicine News(10 mins):